Form 4: Lemaitre Vascular Director Acquires Shares Through Dividend Equivalent Rights Vesting

Director Lawrence J. Jasinski acquired shares of Lemaitre Vascular Inc. common stock through the vesting of dividend equivalent rights associated with restricted stock units and performance stock units.

Summary

• Lawrence J. Jasinski, a director at Lemaitre Vascular Inc., acquired a total of 12 shares of common stock.
• These shares were obtained through the vesting of dividend equivalent rights.
• The dividend equivalent rights were associated with previously granted restricted stock unit awards and performance stock unit awards.
• The transactions occurred on December 11, 2024, and December 12, 2024.
• The director now beneficially owns 5,544 shares of common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation. It is a positive sign that a director is increasing their stake in the company, but it is not a major event that would significantly impact the stock price.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Industry Context

This is a standard SEC Form 4 filing, which is common for company insiders when they acquire or dispose of company stock. It is a routine part of corporate governance and transparency.

Comparison to Industry Standards

• The vesting of restricted stock units and performance stock units is a common practice for executive compensation in publicly traded companies.
• The use of dividend equivalent rights is also a standard method to ensure that holders of unvested equity awards receive the economic equivalent of dividends paid on common stock.
• Similar filings are regularly made by directors and officers of other companies in the medical device industry, such as Boston Scientific and Medtronic, when they receive stock awards or exercise options.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it shows a director's increased stake in the company.

Key Dates

Keywords

Lemaitre Vascular, Director, Share Acquisition, Dividend Equivalent Rights, Restricted Stock Units, Performance Stock Units, LMAT, Beneficial Ownership